MCW: Catheter, Peripheral, Atherectomy
What it covers
An intraluminal artery stripper is a device used to perform an endarterectomy (removal of plaque deposits from arterisclerotic arteries.)
The identification in 21 CFR 870.4875, intraluminal artery stripper. FDA gives MCW no definition of its own, so the regulation’s describes it.
Recent clearances
| 510(k) | Device | Applicant | Decision | Type |
|---|---|---|---|---|
| K260244 | Auryon Atherectomy System | Eximo Medical | Apr 10, 2026 | Traditional |
| K250723 | FreedomFlow Orbital Circumferential Atherectomy System (H6005/ 4Fr 3-Sphere Configuration) | Cardio Flow Inc., | Apr 25, 2025 | Special |
| K250385 | Turbo-Elite Laser Atherectomy Catheter | Spectranetics | Mar 13, 2025 | Special |
| K242757 | Rotarex Atherectomy System | Bard Peripheral Vascular, Inc. | Jan 30, 2025 | Special |
| K242947 | FreedomFlow Orbital Circumferential Atherectomy System | Cardio Flow Inc., | Nov 5, 2024 | Special |
| K241553 | Auryon Atherectomy Catheter 1.7mm; Auryon Atherectomy Catheter 1.7mm, Hydrophilic Coating | Eximo Medical, Ltd. | Jun 27, 2024 | Special |
| K233483 | FreedomFlow Orbital Circumferential Atherectomy System (H6004/5Fr 3-Sphere Configuration) | Cardio Flow Inc., | Feb 15, 2024 | Special |
| K233668 | Auryon Atherectomy Catheter 1.5 mm XL, Hydrophilic Coating (EXM-4010-H000), Auryon Atherectomy Catheter 0.9 mm XL, Hydrophilic Coating (EXM-4011-H000), Auryon Atherectomy Catheter 1.5 mm XL (EXM -4010-0000), Auryon Atherectomy Catheter 0.9 mm XL (EXM-4011-0000) | Eximo Medical, Ltd. | Dec 15, 2023 | Special |
| K231538 | FreedomFlow Orbital Circumferential Atherectomy System | Cardio Flow Inc., | Sep 27, 2023 | Traditional |
| K230709 | Auryon Atherectomy System | Eximo Medical, Ltd. | Jun 9, 2023 | Special |
Clearances by year
77 MCW 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.
| Year | Clearances | Median days to decision |
|---|---|---|
| 2026 (so far) | 1 | 73 |
| 2025 | 3 | 46 |
| 2024 | 3 | 41 |
| 2023 | 4 | 104 |
| 2022 | 6 | 69 |
| 2021 | 6 | 119 |
| 2020 | 2 | 59 |
| 2019 | 3 | 112 |
| 2018 | 8 | 103 |
| 2017 | 7 | 91 |
| 2016 | 5 | 60 |
| 2015 | 6 | 30 |
| 2014 | 7 | 117 |
| 2013 | 5 | 30 |
| 2012 | 5 | 29 |
| 2011 | 6 | 39 |
Who submits
28 applicants cleared a MCW device since 2011. 88% of the clearances went to applicants in United States, then Israel (10%) and Switzerland (1%). By type: Traditional 51% and Special 49%. 1 went through a third-party review organization.
| Applicant | Clearances since 2011 |
|---|---|
| Cardiovascular Systems, Inc. | 13 |
| Avinger, Inc. | 10 |
| Eximo Medical, Ltd. | 7 |
| Spectranetics, Inc. | 6 |
| Volcano Atheromed, Inc. | 6 |
| Cardio Flow Inc., | 4 |
| Medrad, Inc. | 3 |
| Pathway Medical Technologies, Inc. | 3 |
How FDA classifies it
Class II (performance standards).
From 21 CFR 870.4875.
Standards
21 CFR 870.4875 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent MCW clearances declared.
Ask about MCW
Questions about MCW
What is FDA product code MCW?
Product code MCW, “Catheter, Peripheral, Atherectomy” in FDA's classification database, is a Class II device type under 21 CFR 870.4875 (intraluminal artery stripper), reviewed by FDA's Cardiovascular panel. FDA's 510(k) database lists 146 clearances under MCW, 77 of them since 2011.
How many 510(k) clearances are there under MCW?
FDA’s 510(k) database listed 146 clearances under MCW as of Oct 29, 2026, 77 of them decided since 2011; the most recent decision was Apr 10, 2026. The Predicate Finder searches the live database.
How long does FDA take to clear a MCW 510(k)?
For the 5 MCW clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 46 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.
Which companies have the most MCW clearances?
Since 2011: Cardiovascular Systems, Inc. (13), Avinger, Inc. (10), Eximo Medical, Ltd. (7), Spectranetics, Inc. (6) and Volcano Atheromed, Inc. (6). 28 applicants have cleared a MCW device in that time.